Home » Fetroja (Cefiderocol)
Buy Fetroja in India — Price & Availability
Fetroja (cefiderocol) is a siderophore cephalosporin antibiotic given as an intravenous infusion to treat complicated urinary tract infections (cUTI) and hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-negative bacteria, in patients with limited or no alternative treatment options. It is not commercially marketed in India, but can be legally imported on a valid prescription through the Named Patient Program. Indian Pharma Network sources it from licensed US/EU manufacturers and qualified pharmaceutical supply channels with appropriate handling.
Looking to buy Fetroja in India? Fetroja (cefiderocol) is a prescription antibiotic that is not yet commercially marketed in India, but can be legally accessed through the Named Patient Program (NPP).
- Brand name: Fetroja®
- Generic (API): Cefiderocol
- Strength & form: 1 gram of cefiderocol as a lyophilised powder for reconstitution, single-dose vial
- Route: Intravenous (IV) infusion
- Drug class: Siderophore cephalosporin antibacterial
- Manufacturer: Shionogi Inc.
- Availability in India: Via Named Patient import (not locally marketed)
- Prescription: Required — physician (infectious disease) supervised
Fetroja (cefiderocol) is a cephalosporin antibacterial with a unique “siderophore” mechanism: it binds iron and is carried into Gram-negative bacteria through their iron-transport systems (a “Trojan horse” mechanism), then acts like other beta-lactams to disrupt the bacterial cell wall. It is active against many multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa.
It is approved for patients 18 years of age and older for:
- Complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible Gram-negative microorganisms, in patients who have limited or no alternative treatment options.
- Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-negative microorganisms.
To reduce the development of drug-resistant bacteria, Fetroja should be used only to treat infections proven or strongly suspected to be caused by susceptible bacteria. It is a prescription medicine and must be used under physician supervision.
Recommended dosage:
The recommended dose of Fetroja is 2 grams administered every 8 hours by intravenous infusion over 3 hours, in patients with normal or mildly reduced kidney function. The dose is adjusted for patients with reduced or increased kidney clearance, as described in the prescribing information. The usual treatment duration is 7 to 14 days, guided by the site and severity of infection and the patient’s clinical response. Fetroja is given only as a reconstituted and diluted IV infusion. The treating physician always determines the exact dose and duration.
- Increased Risk of Mortality: In one clinical study, patients with certain drug-resistant Gram-negative infections treated with Fetroja had a higher overall mortality than those receiving other treatments. Your doctor will monitor your response carefully.
- Hypersensitivity Reactions: Fetroja may cause serious allergic reactions, including anaphylaxis. Inform your doctor if you have a history of penicillin or cephalosporin allergy. Seek immediate medical attention if allergic symptoms develop.
- Clostridioides difficile-Associated Diarrhoea: Fetroja may cause severe diarrhoea due to Clostridioides difficile infection. Contact your doctor promptly if you experience persistent, severe, or bloody diarrhoea during or after treatment.
- Seizures and Central Nervous System Reactions: Seizures, tremors, confusion, or muscle jerks have been reported with cephalosporin antibiotics, including Fetroja. Inform your doctor immediately if you experience any unusual neurological symptoms during treatment.
Common side effects:
The most common side effects include diarrhoea, infusion-site reactions, constipation, rash, candidiasis, cough, elevated liver tests, headache, low potassium, nausea, and vomiting. This is not a complete list — refer to the full prescribing information and your doctor
Patients in India can legally access Fetroja through the Named Patient Program (NPP) — an import route that allows a medicine not yet registered in India to be imported in an individual patient’s name, on their physician’s prescription. The process is simple and fully documented:
- Share your request — the patient or treating doctor sends the medicine name, required quantity, and destination city.
- Eligibility & document check — we verify the prescription, diagnostic reports, and patient ID against regulatory requirements.
- Receive your quote — a transparent quotation covering medicine cost, logistics, and timeline.
Regulatory approvals — we assist with the import permit and documentation needed for legal cross-border access. - Import & delivery — Fetroja is sourced and shipped under validated, temperature-controlled conditions to the patient or treating hospital.
Documents required to import Fetroja:
- A valid prescription from a qualified physician
- The patient’s diagnostic reports (including culture/susceptibility results where available)
- Government-issued patient ID proof
- An import permit, where applicable
Because Fetroja is not sold on the open market in India, there is no fixed MRP. The Fetroja cost in India depends on a few factors at the time of import:
- The number of 1 g vials required, which is based on the prescribed dose (typically 2 g every 8 hours), the infusion schedule, kidney function, and the treatment duration.
- The sourcing country and current ex-market price (USA, Europe, Canada, Japan, China, or Australia).
- Logistics, insurance, and any applicable customs duties or import permit costs.
Get a transparent quote: We provide a written quotation covering Fetroja cost, logistics, and delivery timeline once a valid prescription is shared. Request your Fetroja quote →
Fetroja is a prescription-only medicine. Pricing is shared with patients, caregivers, and treating hospitals against a valid prescription, in line with applicable regulations.
Indian Pharma Network sources Fetroja from reliable manufacturers and authorised supply channels and facilitates supply to patients, doctors, and hospitals under applicable legal provisions. Fetroja vials should be stored according to the conditions stated on the dispensed carton and package leaflet, in the original packaging, protected from light. All orders are dispensed and checked by registered pharmacists and dispatched after legal requirements are fulfilled.
Detail | Information |
Storage | Store in the original carton per the carton/leaflet instructions; protect from light |
Sourcing regions | USA, Europe, Canada, China, Japan, Australia |
Delivery | To the patient’s address or treating hospital, under appropriate logistics |
Order confirmation | After verification of a valid prescription and import permit (where applicable) |
Is Fetroja available in India?
Fetroja (cefiderocol injections) is a prescription medicine that legally requires a doctor’s prescription to be dispensed. As of the current publicly available information, Fetroja is not commercially marketed in India.
However, patients in India can legally access Fetroja through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of an individual patient, on the prescription of their treating physician.
Indian Pharma Network (IPN) acts as a facilitator under named patient supply, providing input on:
Availability of Fetroja in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.) and pathways to access it
Availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
Fetroja price in India under the NPP route
Sourcing from genuine, reliable channels in the USA, Canada, Europe, and Australia
Ensuring full transparency throughout the process
Fetroja can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient’s treating hospital. Orders are confirmed only upon receipt of a valid doctor’s prescription and, where applicable, an import permit.
Regulatory approval status:
Fetroja first received US FDA approval in November 2019 for complicated urinary tract infections (including pyelonephritis) in adults with limited or no alternative treatment options, with a later approval for hospital-acquired/ventilator-associated bacterial pneumonia. It was designated a Qualified Infectious Disease Product with fast-track and priority review. In the European Union, it was approved (April 2020) under the brand name Fetroja for infections due to aerobic Gram-negative bacteria in adults with limited treatment options. As of the current publicly available information, Fetroja is not commercially marketed in India, which is why the Named Patient route is used.
How does Fetroja Import in India work?
Fetroja Import in India can be done through the Named Patient Program (NPP). This means the medicine can be imported on behalf of the patient with a valid doctor’s prescription. Indian Pharma Network (IPN) helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.
How can I buy Fetroja in India?
Fetroja is not commercially marketed in India, but it can be legally accessed through the Named Patient Program. With a valid prescription, diagnostic reports, and a government-issued patient ID, Indian Pharma Network facilitates compliant import in the patient’s name.
What is the price of Fetroja in India?
Fetroja is not sold on the open market in India, so the cost depends on sourcing, the number of vials required, logistics, and applicable duties at the time of import. A transparent, patient-specific quote is provided once the prescription is verified.
What is Fetroja used for?
It treats complicated urinary tract infections (including pyelonephritis) and hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible Gram-negative bacteria, in patients 18 and older with limited or no alternative options.
Who is a reliable Fetroja supplier in India?
Indian Pharma Network (IPN) is a trusted Fetroja supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.
Who manufactures Fetroja?
Fetroja is manufactured by Shionogi.
What is the dosage form and strength of Fetroja?
Fetroja is supplied as 1 gram of cefiderocol lyophilised powder in a single-dose vial, reconstituted and given by IV infusion. The usual dose is 2 g every 8 hours (adjusted for kidney function).
Who is an authorized Fetroja importer in India?
Indian Pharma Network (IPN) acts as a Fetroja importer in India. We help with Named Patient Import processes, regulatory documentation, and compliant procurement from leading international manufacturers for patients who need this therapy.
How is Fetroja stored and delivered?
Fetroja vials are stored in the original carton per the manufacturer’s instructions, protected from light, and shipped under appropriate conditions to the patient or treating hospital.
Request Fetroja price & availability:
Speak with our patient support team for Fetroja price, availability, quote, and guidance on the Named Patient import process. We respond within 24 hours on business days.
- Call: +91-96548 60915
- WhatsApp: +91-98104 69557
- Toll-free: 1800-1200-365
- Email: info@indianpharmanetwork.in
References & sources
- Fetroja (cefiderocol) US Prescribing Information, Shionogi Inc.
- US Food & Drug Administration — Fetroja approval (cUTI, November 2019; HABP/VABP added subsequently).
- European Medicines Agency — Fetroja product information.
- Drug.com- Fetroja FDA Approval History
Content reviewed by the Indian Pharma Network clinical content team. Indications, dosing, and safety information are summarised from the manufacturer’s prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
Fetroja® (cefiderocol for injection) is a prescription antibiotic and should only be used under the supervision of a qualified healthcare professional. Indian Pharma Network is a pharmaceutical trading entity that facilitates access to medicines through legally permissible channels, such as Named Patient import, strictly against valid prescriptions. All trademarks and brand names remain the property of their respective owners (Fetroja® is a registered trademark of Shionogi) and are used for identification only. This page is for informational purposes and does not constitute medical advice. Product availability, import requirements, and pricing vary by country-specific regulations.